Imerys Stock: Nearly 6% Drop Following Earnings Release
Imerys shares fell sharply this Friday morning, down 5.75% at 23.92 euros, following the announcement of its annual results. The mining group confirmed it met its 2025 forecasts while unveiling a major cost-saving plan named Project Horizon. This downward reaction extends a difficult week for the stock, which has declined more than 10% over seven days.
Financial Performance and Strategic Initiatives
Imerys confirmed on Friday that it achieved an adjusted EBITDA of 546 million euros in 2025, in line with its initial target, in a context described by the group as lackluster demand. Simultaneously, the company announced the launch of Project Horizon, a structural program aimed at generating between 50 and 60 million euros in recurring savings starting in 2026. This cost reduction plan reflects the management's intention to preserve profitability in an ever-challenging industrial environment. Despite this confirmation of trajectory and the prospect of significant productivity gains, the stock sharply dropped at the opening. The current price of 23.92 euros brings the annual performance to -14.88%, highlighting the ongoing pressure on the valuation of this industrial minerals specialist. Over three months, however, the stock still holds a residual gain of 5.65%, indicating that the bulk of the correction has been concentrated in recent sessions.
Technical Analysis of the Day's Trading
From a technical standpoint, today's session marks a significant break. The Imerys stock fell below its support at 24.30 euros, a level that had been a reference floor in recent weeks. This break is accompanied by a drop below the 200-day moving average, set at 24.60 euros, indicating a deterioration of the underlying trend after a period of relative stabilization. The RSI, a momentum indicator measuring the strength of the ongoing movement, stands at 42, in an intermediate but declining zone, consistent with the observed bearish acceleration. This level does not yet indicate an extreme oversold situation, which leaves open the possibility of a continuation of the corrective movement underway. The next major resistance zone is at 27.94 euros, a significant gap from the current price.
